跳至主要内容
临床试验/JPRN-UMIN000012434
JPRN-UMIN000012434已完成4 期

The study on the preventive effect of irsogladine for gastric bleeding risk of antithrombotic drugs after ESD -multicenter randomized controlled study of irsogladine + PPI versus PPI alone- - The study on the preventive effect of irsogladine for gastric bleeding risk of antithrombotic drugs after ESD

Osaka Medical College0 个研究点目标入组 200 人开始时间: 2013年11月28日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Subjects with hematemesis, melena or anemia lack of hemoglobin 2 g/dL or more during the observation period 2)Subjects with significant hepatic disease, renal disease, heart disease or respiratory disease 3)Subjects with a history of gastrointestinal surgery other than appendectomy 4)Subjects orally taking or planning to orally take drug other than rabeprazole or irsogladine 5)Pregnancy or lactation 6)Subjects whom otherwise the investigator determined ineligible as the subject

研究者

相似试验